Trial Profile
Paricalcitol Action on Parameters of Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease Stage Vd Carriers Tunneled Hemodialysis Catheters.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2014
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary) ; Atorvastatin
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms SENPARIC
- 08 Aug 2014 New trial record